Jabbour Richard J, Tanaka Akihito, Colombo Antonio, Latib Azeem
Imperial College London United Kingdom.
EMO-GVM Centro Cuore Columbus Milan, Italy.
Interv Cardiol. 2018 Sep;13(3):137-139. doi: 10.15420/icr.2018.24.2.
Transcatheter aortic valve implantation has revolutionised the treatment of patients with severe aortic stenosis and is the preferred treatment option for patients with elevated surgical risk. Outcomes have continually improved, but because of the nature of the procedure infrequent catastrophic complications, such as coronary obstruction, persist. Recently, data were published regarding delayed coronary obstruction (DCO), a phenomenon in which the obstruction occurs after the index procedure. DCO has important consequences for future research. In this article we will explore the implications for new transcatheter heart valve design and approaches to patient management to minimise the risk of DCO occurring.
经导管主动脉瓣植入术彻底改变了严重主动脉瓣狭窄患者的治疗方式,是手术风险较高患者的首选治疗方案。治疗效果不断改善,但由于该手术的性质,诸如冠状动脉阻塞等罕见的灾难性并发症仍然存在。最近,有关延迟性冠状动脉阻塞(DCO)的数据已发表,这是一种在初次手术后发生阻塞的现象。DCO对未来的研究具有重要影响。在本文中,我们将探讨其对新型经导管心脏瓣膜设计以及患者管理方法的影响,以尽量降低发生DCO的风险。